4.4.1 Important safeguards/notices for use in healthcare applications
All the equipment connected to this unit shall be certified per Standard IEC 60601-1,
IEC60950-1, IEC60065 or other IEC/ISO Standards applicable to the equipment.
Furthermore, all configurations shall comply with the system standard IEC60601-1.
Everybody who connects additional equipment to the signal input part or signal output part
configures a healthcare system, and is therefore, responsible that the system complies with
the requirements of the system standard IEC60601-1.
If in doubt, consult the qualified service personnel.
The leakage current could increase when connected to other equipment.
For this equipment, all accessory equipment connected as noted above, must be connected
to mains via an additional isolation transformer conforming to the construction requirements
of IEC60601-1 and providing at least basic insulation.
This equipment generates, uses, and can radiate radio frequency energy. If it is not
installed and used in accordance with the instruction manual, it may cause interference to
other equipment. If this unit causes interference (which can be determined by unplugging
the power cord from the unit), try these measures: Relocate the unit with respect to the
susceptible equipment. Plug this unit and the susceptible equipment into different branch
circuit.
4.4.2 Important EMC notices for use in healthcare applications
The W32L100-PTA1 needs special precautions regarding EMC and needs to be installed
and put into service per the EMC information provided in the instructions for use.The
portable and mobile RF communications equipment such as cellular phones can affect the
W32L100-PTA1
WARNING!
The use of accessories and cables other than those
specified, with the exception of replacement parts sold by Winmate Inc.,
may result in increased emissions or decreased immunity of the
W32L100-PTA1.
AVERTISSEMENT!
L'utilisationd'accessoires et de
câblesautresqueceuxspécifiés, à l'exception des pièces de
rechangevendues par Winmate Inc., peutentraînerune augmentation des
émissionsouune diminution de l'immunité du W32L100-PTA1.
